El uso de frmacos anlogos del GLP-1 est asociado con beneficios pero tambin riesgos para la salud El uso de agonistas del receptor del pptido similar al glucagn tipo 1 (GLP-1RAs, por sus siglas en ingls), utilizados para tratar la diabetes y la obesidad, podra estar asociado con un amplio espectro de efectos sobre la salud, tanto positivos como un menor riesgo de trastornos cardiometablicos como negativos un mayor riesgo de afecciones gastrointestinales o hipertensin
Some individuals find their optimal tolerated dose is below 3.0 mg
Maybe we do not need all of those things for people to be successful
If you take oral medications, talk with your clinician about timing, because slowed gastric emptying can change how quickly some medicines feel like they work
(1995) found increased ligamentous strength and density in animal models treated with prolotherapy
Less fluid in the gut means: Less lubrication Firmer stools Slower transit Dehydration also concentrates electrolytes like calcium, which can have constipating effects